← Back to Search

Vibratory Anesthesia for Trigger Finger

Phase 4
Recruiting
Led By Tolga Turker, MD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the trigger finger injection is completed
Awards & highlights

Study Summary

This trial will compare the effectiveness of no topical anesthesia, topical coolant, and vibration in reducing pain during trigger finger injections.

Who is the study for?
This trial is for healthy adults diagnosed with trigger finger who need a steroid injection as part of their treatment. It's not suitable for those without a trigger finger diagnosis, those who don't require an injection, or individuals with reduced touch sensation in the affected area.Check my eligibility
What is being tested?
The study compares three methods to reduce pain during trigger finger injections: no anesthesia, a topical coolant spray (Gebauers Ethyl Chloride), and vibration anesthesia device by Blaine Labs. Patients will be randomly assigned to one of these methods.See study design
What are the potential side effects?
Potential side effects may include temporary discomfort at the site of application for both the topical coolant and vibration device. There are generally no significant side effects expected from these types of local anesthesia techniques.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the trigger finger injection is completed
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the trigger finger injection is completed for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Felt

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: VibrationExperimental Treatment1 Intervention
The subject will have a vibration device placed just proximal to the site of the trigger finger injection concurrent with the administration of the injection.
Group II: Topical coolantExperimental Treatment1 Intervention
The subject will have 5 seconds of sterile ethyl chloride sprayed at the site of the trigger finger injections just prior to the administration of the injection.
Group III: No topical anesthesiaActive Control1 Intervention
No topical anesthesia will be given during the trigger finger injection.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
514 Previous Clinical Trials
147,594 Total Patients Enrolled
Tolga Turker, MDPrincipal InvestigatorAssociate Professor
1 Previous Clinical Trials
80 Total Patients Enrolled

Media Library

Gebauers Ethyl Chloride 100% Topical Spray Clinical Trial Eligibility Overview. Trial Name: NCT05405452 — Phase 4
Trigger Finger Research Study Groups: Vibration, No topical anesthesia, Topical coolant
Trigger Finger Clinical Trial 2023: Gebauers Ethyl Chloride 100% Topical Spray Highlights & Side Effects. Trial Name: NCT05405452 — Phase 4
Gebauers Ethyl Chloride 100% Topical Spray 2023 Treatment Timeline for Medical Study. Trial Name: NCT05405452 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility window for this trial still open?

"Clinicaltrials.gov reports that this trial, which was first uploaded to the database on June 1st 2022 and last edited on May 31st 2022, is not actively recruiting any more participants; however, there are currently 401 other studies seeking enrolment."

Answered by AI
~652 spots leftby Aug 2025